FDA relaxes clinical hold on Translate Bio’s cystic fibrosis drug

FDA relaxes clinical hold on Translate Bio’s cystic fibrosis drug

Source: 
Fierce Biotech
snippet: 

RNA specialist Translate Bio is just weeks away from dosing the first patients in its phase 1/2 trial in cystic fibrosis patients after a green light from the FDA.